| Business Summary | | Pharmaceutical
Product
Development,
Inc.
and
its
subsidiaries
provide
a
broad
range
of
research
and
development
and
consulting
services
in
two
segments,
development
and
discovery
sciences.
In
the
development
segment,
the
Company
provides
worldwide
clinical
research
and
development
of
pharmaceutical
products
and
medical
devices,
biostatistical
analysis
and
analytical
laboratory
services.
The
discovery
sciences
services
include
target
identification
and
validation,
compound
creation,
screening
and
compound
selection.
The
Company
provides
services
under
contract
to
clients
in
the
pharmaceutical,
general
chemical,
agrochemical,
biotechnology
and
other
industries.
In
addition,
the
Company
performs
discovery
research
on
certain
compounds
for
which
it
holds
a
license.
Development
services
are
marketed
primarily
in
the
United
States
and
Europe. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Pharmaceutical
Product
Development
provides
a
range
of
research
and
development
and
consulting
services
in
the
development
and
discovery
science
segments.
For
the
six
months
ended
6/30/01,
revenues
rose
26%
to
$209
million.
Net
income
increased
84%
to
$25
million.
Revenues
reflect
an
increase
in
the
size
and
number
of
contracts
in
the
global
CRO
Phase
II-IV
division.
Earnings
also
reflect
increased
margins
and
cost
control
measures. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Ernest Mario, Ph.D., 62 Chairman | -- | -- | Fredric Eshelman, Ph.D., 52 Vice
Chairman and CEO | $711K | $391K | Philippe Maitre, 44 CFO,
VP-Fin., Treasurer | 139K | -- | Fred Davenport, Jr., 49 Exec.
VP | 329K | 90K | Francis Casieri, 58 Sr.
VP - Global Bus. Devel. | 214K | 23K | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|